Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
May 2020
in “
Frontiers in Pharmacology
”
5α-reductase inhibitors α1-adrenoceptor antagonists muscarinic receptor antagonists beta-3 adrenoceptor agonists mirabegron phosphodiesterase 5 inhibitors tadalafil benign prostatic hyperplasia lower urinary tract symptoms prostate volume PSA levels 5-alpha reductase inhibitors alpha-1 blockers beta-3 agonists PDE5 inhibitors Cialis BPH LUTS
Studysummary This review provides a comprehensive overview of the mechanisms, efficacy, and adverse reactions of drugs commonly used for treating benign prostatic hyperplasia but reports no new clinical results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on frontiersin.org →